
Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities – Modules 1 & 2
This CME program will highlight evidence based dietary and pharmacologic approaches to manage patients with hyperkalemia. Starting with module 1, Dr. Biff Palmer will review the science of recurrent hyperkalemia, including relationships between dietary potassium intake, serum potassium, and patient morbidities. Next, in module 2, Dr. Pamela Kushner will evaluate the limitations and impact of plant-based diets and potassium restricted ...
View Course

The Role of Neonatal Fc Receptor (FcRn) Blocking Therapeutics in the Management of Patients with Generalized Myasthenia Gravis
View Course

Update on Best Practices for the Prompt and Personalized Management of Patients with COPD Exacerbations
View Course

Advances in the Diagnosis and Management of Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE): The Role of Dipeptidyl Peptidase 1 (DPP1) Inhibitor Therapeutics
View Course

Advances in the Diagnosis and Management of Patients with Non-Tuberculin Mycobacterial Lung Disease: The Role of Amikacin-Based Inhalation Therapeutics
View Course

An Update on the Assessment and Therapeutic Management of Cognitive Decline in Patients with Multiple Sclerosis
View Course

Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Patients with Diabetes
This CME/CE program will provide clinicians with an update on treatment strategies for basal insulins to manage time-in-range and glucose variability to improve outcomes in patients with diabetes. The expert faculty will review the importance of the role of the diabetes care and education specialist to minimize glucose variability in patients on longer-acting insulins. Next, a clinical review of newer longer-acting ...
View Course

Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Patients with Diabetes
This CME program will highlight treatment strategies for basal insulins to manage time-in-range and glucose variability to improve outcomes in patients with diabetes. The expert faculty, Dr. Neil S. Skolnik, will outline the importance of improving patients’ glucose to time-in-range, minimize glucose variability, and incorporate continuous glucose monitoring in patients with diabetes. Following, Dr. Skolnik will discuss how to distinguish ...
View Course

Update on the Safety and Efficacy of JAK Inhibitor Therapeutics for the Treatment of Atopic Dermatitis
View Course

The Impact of the COVID Pandemic on Continuity of Care and Adherence to DAPT Among Patients with CAD/ACS/PCI
View Course